Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Express Scripts
McKinsey
AstraZeneca
Johnson and Johnson

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Anthrax vaccine

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Anthrax vaccine?

Anthrax vaccine is an investigational drug.

There have been 14 clinical trials for Anthrax vaccine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2015.

The most common disease conditions in clinical trials are Anthrax, Cystitis, and Cystic Fibrosis. The leading clinical trial sponsors are Department of Health and Human Services, Bayer, and National Institute of Allergy and Infectious Diseases (NIAID).

There are twelve US patents protecting this investigational drug and fifty-five international patents.

Recent Clinical Trials for Anthrax vaccine
TitleSponsorPhase
Velocity 2: An Anthrax Vaccine and Antibiotics Clinical StudyBiomedical Advanced Research and Development AuthorityPhase 2
Velocity 2: An Anthrax Vaccine and Antibiotics Clinical StudyEmergent Product Development Gaithersburg, Inc.Phase 2
BARDA Securing Anthrax Immunity For the ElderlyRho, Inc.Phase 2

See all Anthrax vaccine clinical trials

Clinical Trial Summary for Anthrax vaccine

Top disease conditions for Anthrax vaccine
Top clinical trial sponsors for Anthrax vaccine

See all Anthrax vaccine clinical trials

US Patents for Anthrax vaccine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Anthrax vaccine   Start Trial Albumin derivatives and variants ALBUMEDIX LTD (Nottingham, GB)   Start Trial
Anthrax vaccine   Start Trial Flagellin-based agents and uses including effective vaccination GENOME PROTECTION, INC. (Buffalo, NY)   Start Trial
Anthrax vaccine   Start Trial Temperature stable vaccine formulations Emergent Product Development Gaithersburg Inc. (Gaithersburg, MD)   Start Trial
Anthrax vaccine   Start Trial Bioadhesive delivery system for transmucosal delivery of beneficial agents SRI International (Menlo Park, CA)   Start Trial
Anthrax vaccine   Start Trial Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A (N/A)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Anthrax vaccine

Drugname Country Document Number Estimated Expiration Related US Patent
Anthrax vaccine China 102939304 2030-04-09   Start Trial
Anthrax vaccine China 106977608 2030-04-09   Start Trial
Anthrax vaccine European Patent Office 2556087 2030-04-09   Start Trial
Anthrax vaccine Japan 2013523145 2030-04-09   Start Trial
Anthrax vaccine Japan 2017031136 2030-04-09   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Moodys
McKinsey
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.